查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2081976

動物生物技術市場：全球市場按產品類型、技術、動物種類、應用和最終用戶分類的預測－2026-2032年

Animal Biotechnology Market by Product Type, Technology, Animal Type, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物生物技術市場將成長至 605.6 億美元，複合年成長率為 8.68%。

主要市場統計數據
基準年 2025 338.1億美元
預計年份：2026年 364.9億美元
預測年份 2032 605.6億美元
複合年成長率 (%) 8.68%

動物生物技術執行摘要

動物生物技術正從一個專門的研究領域轉變為核心技術，為糧食安全、動物健康、永續畜牧業、水產養殖生產力以及生物醫學研究提供支援。此領域涵蓋動物基因組學、分子診斷、生殖生物技術、基因編輯、疫苗、生技藥品、微生物組解決方案、基因改造和克隆動物模型以及精準育種工具，這些技術廣泛應用於家畜、伴侶動物、實驗動物和水生生物。

動物生物技術的變革性變化

基因組學、合成生物學、自動化和數據主導的動物健康管理正在融合重塑動物生物技術的模式。基因組選擇現已廣泛應用於乳牛、家禽、豬和水產養殖的育種計畫中，以提高生產力、抗病性、繁殖力、飼料轉換率和適應能力。同時，基於CRISPR的基因編輯技術正在加速對能夠降低疾病易感性、改善動物福利和支持更永續生產系統的性狀的研究。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過提高發現和現場應用的速度、準確性和擴充性，進一步擴大了動物生物技術的影響力。 AI 驅動的基因組分析有助於識別與經濟性狀相關的標記，而機器學習模型可以透過整合表現型、基因型、飼料、環境和健康記錄來支持育種決策。在獸醫學領域，AI 的應用日益廣泛，涵蓋診斷影像、病原體檢測、集體爆發建模、藥物安全監測和精準給藥研究等領域。

對關鍵區域的洞察

亞太地區是動物生物技術的重點發展區域。這主要得益於該地區對動物性蛋白質的旺盛需求、大規模水產養殖、家禽和生豬養殖的集約發展，以及中國、印度、日本、韓國和澳洲等國政府主導的生物技術計畫。在該地區，人們越來越關注疫苗、分子診斷、生豬生物安全、蝦類和魚類健康管理、基因組選擇以及繁殖技術，旨在提高不同生產系統的生產力並減少疾病損失。

關鍵群體特定見解

在東協，動物生物技術在禽類、水產養殖和生豬養殖生產中的重要性日益凸顯。這主要是由於各國政府在大規模跨境疾病爆發後加強了疾病監測和生物安全措施。該地區的需求與快速診斷、疫苗、育種改良、水產養殖健康管理以及可在集約化和小規模養殖系統中實施的實用技術密切相關。

主要國家的概況

美國在動物生物技術的商業化方面處於領先地位，其優勢體現在先進的動物基因組學、獸用生技藥品、伴侶動物療法、分子診斷以及產學研合作等方面。加拿大在畜牧遺傳學、疫苗研發、乳牛和肉牛產業的創新以及動物健康監測方面擁有優勢。同時，墨西哥正在拓展與家禽、肉牛、乳牛和生豬供應鏈相關的獸醫診斷和生產技術。巴西是重要的樞紐，在全球牛肉和家禽出口中扮演著重要角色，這得益於其在育種、繁殖技術、疫苗和生物安全方面的投資。

為行業領導者提供的實用建議

產業領導者應優先考慮已驗證的、可直接應用於實際養殖的動物生物技術解決方案，以應對諸如疾病損失、繁殖效率、飼料轉換率、動物福利、耐熱性、水產養殖死亡率以及減少抗生素使用等可衡量的挑戰。各組織可以透過將生物技術產品與診斷技術、數據平台、培訓、獸醫支持以及面向生產者、獸醫、監管機構和公共衛生利益相關人員的以結果為導向的證據相結合，來加速生物技術產品的推廣應用。

調查方法

本調查方法是基於整合公開且機構資訊來源的二手資料，包括聯合國糧農組織（FAO）、世界動物衛生組織（WOAH）、世界衛生組織（WHO）、經濟合作暨發展組織（OECD）、美國農業部（USDA）、美國食品藥物管理局（FDA）、歐洲藥品管理局（EMA）、歐洲食品安全局（EFSA）、美國農業部門審查管理局（FDA）、歐洲藥品資料庫（EMA）、歐洲出版刊物安全資訊來源（EFSA）、本分析檢驗在於動物基因組學、獸用生技藥品、分子診斷、生殖生物技術、基因編輯、水產養殖生物技術、微生物組科學和人工智慧驅動的動物健康等領域的可驗證趨勢。

結論

動物生物技術正成為畜牧業、獸醫學、水產養殖、生物醫學研究和永續蛋白質生產等領域的重要策略支柱。在人們日益關注疾病威脅、氣候風險、合理使用抗生素、通用感染疾病和糧食安全等問題的背景下，生物技術驅動的育種、診斷、疫苗、生技藥品和人工智慧分析將在提高動物生產力、健康和福利方面發揮更大的作用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 動物生物技術市場：依產品類型分類

  • 重組蛋白
    • 抗體
    • 酵素
      • 脂肪酶
      • 植酸酶
      • 蛋白酶
    • 生長激素
  • 疫苗
    • DNA疫苗
    • 去活化疫苗
    • 減毒活疫苗
    • 次單位疫苗

第8章：動物生物技術市場：依技術分類

  • 細胞培養
    • 禽類細胞培養
    • 昆蟲細胞培養
    • 哺乳動物細胞培養
  • 基因工程
    • 基因編輯
    • 基因合成
    • 基因改造技術
  • PCR和DNA定序
    • 次世代定序
    • PCR試劑盒
    • 桑格定序

第9章：動物生物技術市場：依動物類型分類

  • 家畜
    • 牛
    • 家禽
    • 豬
  • 伴侶動物
    • 狗
    • 貓

第10章 動物生物技術市場：依應用領域分類

  • 診斷
    • ELISA試劑盒
    • 橫向流動化驗
    • 基於PCR的檢測
  • 藥物發現
    • 先導藥物最適化
    • 臨床前試驗
    • 目標識別
  • 飼料添加劑
    • 碳水化合物消化酶
    • 植酸酶
    • 蛋白酶

第11章 動物生物技術市場：依最終用戶分類

  • 畜牧場
  • 受託研究機構
  • 製藥公司
  • 研究所

第12章 動物生物技術市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：動物生物技術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 動物生物技術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abaxis, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioChek BV
  • Biogenesis Bago SA
  • Bioniche Life Sciences Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Covetrus, Inc.
  • Creative Biolabs, Inc.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Genus plc
  • Henry Schein Animal Health
  • Heska Corporation
  • Hester Biosciences Limited
  • IDEXX Laboratories, Inc.
  • IDvet SAS
  • ImmuCell Corporation
  • Indian Immunologicals Limited
  • INDICAL Bioscience GmbH
  • Intas Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Neogen Corporation
  • Neovet Diagnostics Pvt. Ltd.
  • Pharmgate Animal Health LLC
  • Phibro Animal Health Corporation
  • Randox Laboratories Ltd.
  • Recombinetics, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Sequent Scientific Limited
  • Thermo Fisher Scientific Inc.
  • Trans Ova Genetics, LC
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-437517DB6EAD

The Animal Biotechnology Market is projected to grow by USD 60.56 billion at a CAGR of 8.68% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 33.81 billion
Estimated Year [2026] USD 36.49 billion
Forecast Year [2032] USD 60.56 billion
CAGR (%) 8.68%

Animal Biotechnology Executive Summary

Animal biotechnology is moving from a specialized research discipline into a core enabler of food security, animal health, sustainable livestock production, aquaculture productivity, and biomedical research. The field includes animal genomics, molecular diagnostics, reproductive biotechnology, gene editing, vaccines, biologics, microbiome solutions, transgenic and cloned animal models, and precision breeding tools used across livestock, companion animals, laboratory animals, and aquatic species.

Demand is supported by structural pressures documented by global agencies, including rising protein consumption, the need to control zoonotic diseases, antimicrobial resistance concerns, and climate-related stress on animal production systems. FAO, WHO, WOAH, and OECD evidence consistently shows that animal disease outbreaks can disrupt trade, food supply, farm income, and public health systems, making preventive animal health technologies, genomic selection, and rapid diagnostics increasingly strategic for producers, governments, veterinarians, and life science stakeholders.

Transformative Shifts in Animal Biotechnology

The animal biotechnology landscape is being reshaped by the convergence of genomics, synthetic biology, automation, and data-led animal health management. Genomic selection is now widely used in dairy, poultry, swine, and aquaculture breeding programs to improve productivity, disease resistance, fertility, feed efficiency, and resilience, while CRISPR-based gene editing is accelerating research into traits that can reduce disease susceptibility, improve animal welfare, and support more sustainable production systems.

Another transformative shift is the movement from reactive treatment to preventive and predictive animal health. Rapid PCR, sequencing-based diagnostics, recombinant vaccines, monoclonal antibodies, and herd-level surveillance systems are enabling earlier intervention. At the same time, regulatory scrutiny, consumer acceptance, animal welfare expectations, antimicrobial stewardship, and traceability requirements are shaping commercialization pathways for genetically engineered animals and biotechnology-derived products.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the impact of animal biotechnology by improving the speed, accuracy, and scalability of discovery and field deployment. AI-driven genomic analysis helps identify markers linked to economically important traits, while machine learning models can support breeding decisions by integrating phenotype, genotype, feed, environment, and health records. In veterinary medicine, AI is increasingly applied to image interpretation, pathogen detection, outbreak modeling, pharmacovigilance, and precision dosing research.

The cumulative effect is a shorter innovation cycle across animal biotechnology. AI-enabled laboratories can prioritize vaccine antigens, optimize biologics development, and interpret high-throughput sequencing data more efficiently. On farms and in aquaculture systems, AI tools connected to sensors, cameras, wearables, electronic identification, and diagnostics support early disease detection and welfare monitoring, helping reduce losses and improve productivity when implemented with validated datasets, strong cybersecurity, interoperable data systems, and transparent governance.

Key Regional Insights

Asia-Pacific is a high-priority region for animal biotechnology, driven by large animal protein demand, aquaculture scale, poultry and swine intensification, and government-backed biotechnology programs in China, India, Japan, South Korea, and Australia. The region is increasingly focused on vaccines, molecular diagnostics, swine biosecurity, shrimp and fish health, genomic selection, and reproductive technologies to improve productivity and reduce disease-related losses across diverse production systems.

North America remains a leading region for animal biotechnology due to advanced veterinary biopharma capabilities, strong university research, established livestock genetics infrastructure, and regulatory experience with biotechnology-derived animal products. The United States and Canada benefit from large commercial livestock industries, companion animal health spending, genomic evaluation systems, and mature disease surveillance networks that support precision breeding, veterinary biologics, and One Health preparedness.

Latin America, led by Brazil and Mexico, is adopting animal genetics, reproductive technologies, vaccines, and diagnostics to improve export competitiveness in beef, poultry, dairy, and swine. Europe is shaped by strong animal welfare rules, rigorous biosafety oversight, and public investment in genomics, vaccines, alternatives to antimicrobials, and One Health surveillance, with the European Union's regulatory framework influencing adoption timelines. The Middle East is investing in food security, veterinary diagnostics, biosecure production, camel health, and small ruminant health, while Africa's opportunity is linked to disease control, heat-tolerant breeds, vaccine access, molecular diagnostics, and productivity improvement for smallholder and commercial livestock systems.

Key Group Insights

ASEAN is gaining relevance in animal biotechnology through poultry, aquaculture, and swine production, especially as governments strengthen disease surveillance and biosecurity after major transboundary disease events. The region's needs are closely tied to rapid diagnostics, vaccines, breeding improvement, aquaculture health, and practical technologies that can be deployed across both intensive and smallholder systems.

GCC markets are focused on food security, import substitution, high-value animal health, and biotechnology applications suited to arid environments and regional livestock systems, including camel, dairy, poultry, and small ruminant production. The European Union provides one of the most influential policy environments for animal biotechnology through harmonized standards for veterinary medicines, food safety, animal welfare, environmental risk assessment, and antimicrobial reduction, creating a demanding but high-value environment for compliant diagnostics, vaccines, and breeding technologies.

BRICS countries are critical to production scale and technology adoption, with China, India, and Brazil playing major roles in livestock, aquaculture, vaccine manufacturing, genomics, and disease control. G7 countries are central to animal biotechnology innovation because they combine advanced research infrastructure, mature veterinary pharmaceutical ecosystems, strong intellectual property systems, and regulatory science. NATO members add a biosecurity dimension, with zoonotic disease preparedness, supply chain resilience, laboratory capability, and surveillance systems becoming increasingly important for national security and food system resilience planning.

Key Country Insights

The United States leads in animal biotechnology commercialization through advanced animal genomics, veterinary biologics, companion animal therapeutics, molecular diagnostics, and academic-industry collaboration. Canada is strong in livestock genetics, vaccine research, dairy and beef innovation, and animal health surveillance, while Mexico is expanding veterinary diagnostics and production technologies linked to poultry, beef, dairy, and swine supply chains. Brazil is a major platform because of its global role in beef and poultry exports, supported by breeding, reproductive technologies, vaccines, and biosecurity investment.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong capabilities in veterinary research, livestock genetics, animal welfare science, diagnostics, and vaccine development, although adoption of gene-edited animals depends on evolving regulatory pathways and consumer acceptance. Russia remains relevant in livestock disease control, domestic vaccine capacity, veterinary surveillance, and agricultural biotechnology priorities.

China is scaling animal biotechnology through genomics, gene editing research, vaccines, swine biosecurity, disease surveillance, and aquaculture innovation. India's opportunity is tied to dairy productivity, animal vaccines, reproductive technologies, molecular diagnostics, and disease control for a large livestock base. Japan and South Korea emphasize precision animal health, advanced diagnostics, biotechnology research, biosecurity, and high-value livestock systems, while Australia is important for livestock genetics, biosecurity, reproductive biotechnology, disease preparedness, and export-oriented animal health standards.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize validated, field-ready animal biotechnology solutions that address measurable pain points such as disease losses, reproductive efficiency, feed conversion, animal welfare, heat stress resilience, aquaculture mortality, and antimicrobial reduction. Organizations can improve adoption by pairing biotechnology products with diagnostics, data platforms, training, veterinary support, and outcome-based evidence for producers, veterinarians, regulators, and public health stakeholders.

Strategic investment should focus on genomic selection, rapid diagnostics, next-generation vaccines, biologics, microbiome products, reproductive biotechnology, aquaculture health, and AI-enabled decision support. Leaders should also build regulatory affairs capabilities early, establish transparent animal welfare and biosafety documentation, protect genomic and farm data, validate claims through field trials, and form partnerships with universities, reference laboratories, producer groups, and public health agencies to strengthen credibility and market access.

Research Methodology

Research methodology is based on secondary research that synthesizes publicly available and institutionally recognized sources, including FAO, WOAH, WHO, OECD, USDA, FDA, EMA, EFSA, national agriculture departments, peer-reviewed journals, patent databases, regulatory publications, and veterinary industry sources. The analysis focuses on verifiable trends in animal genomics, veterinary biologics, molecular diagnostics, reproductive biotechnology, gene editing, aquaculture biotechnology, microbiome science, and AI-enabled animal health.

The research approach evaluates technology maturity, regulatory direction, regional production systems, disease burden, commercialization readiness, animal welfare considerations, biosecurity priorities, and adoption drivers. Insights are triangulated across scientific evidence, public policy, regulatory activity, market deployment patterns, and industry use cases to support an authoritative view of the animal biotechnology landscape without relying on unverified claims, market sizing, market share, or forecasting.

Conclusion

Animal biotechnology is becoming a strategic pillar for resilient animal agriculture, veterinary medicine, aquaculture, biomedical research, and sustainable protein production. As disease pressure, climate risk, antimicrobial stewardship, zoonotic threats, and food security concerns intensify, biotechnology-enabled breeding, diagnostics, vaccines, biologics, and AI-supported analytics will play a larger role in improving animal productivity, health outcomes, and welfare.

The next phase of advancement will be defined by responsible innovation. Organizations that combine scientific validation, regulatory readiness, ethical governance, biosafety, transparent data practices, and clear economic value for producers and veterinarians will be best positioned to lead in the animal biotechnology landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Animal Biotechnology Market, by Product Type

  • 7.1. Recombinant Proteins
    • 7.1.1. Antibodies
    • 7.1.2. Enzymes
      • 7.1.2.1. Lipases
      • 7.1.2.2. Phytases
      • 7.1.2.3. Proteases
    • 7.1.3. Growth Hormones
  • 7.2. Vaccines
    • 7.2.1. DNA Vaccines
    • 7.2.2. Inactivated Vaccines
    • 7.2.3. Live Attenuated Vaccines
    • 7.2.4. Subunit Vaccines

8. Animal Biotechnology Market, by Technology

  • 8.1. Cell Culture
    • 8.1.1. Avian Cell Culture
    • 8.1.2. Insect Cell Culture
    • 8.1.3. Mammalian Cell Culture
  • 8.2. Genetic Engineering
    • 8.2.1. Gene Editing
    • 8.2.2. Gene Synthesis
    • 8.2.3. Transgenic Technology
  • 8.3. PCR And DNA Sequencing
    • 8.3.1. Next-Generation Sequencing
    • 8.3.2. PCR Kits
    • 8.3.3. Sanger Sequencing

9. Animal Biotechnology Market, by Animal Type

  • 9.1. Livestock
    • 9.1.1. Cattle
    • 9.1.2. Poultry
    • 9.1.3. Swine
  • 9.2. Companion Animals
    • 9.2.1. Dogs
    • 9.2.2. Cats

10. Animal Biotechnology Market, by Application

  • 10.1. Diagnostics
    • 10.1.1. ELISA Kits
    • 10.1.2. Lateral Flow Assays
    • 10.1.3. PCR-Based Tests
  • 10.2. Drug Discovery
    • 10.2.1. Lead Optimization
    • 10.2.2. Preclinical Testing
    • 10.2.3. Target Identification
  • 10.3. Feed Additives
    • 10.3.1. Carbohydrases
    • 10.3.2. Phytases
    • 10.3.3. Proteases

11. Animal Biotechnology Market, by End-User

  • 11.1. Animal Farms
  • 11.2. Contract Research Organizations
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Laboratories

12. Animal Biotechnology Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Animal Biotechnology Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Animal Biotechnology Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abaxis, Inc.
  • 16.2. Bio-Rad Laboratories, Inc.
  • 16.3. BioChek B.V.
  • 16.4. Biogenesis Bago S.A.
  • 16.5. Bioniche Life Sciences Inc.
  • 16.6. Boehringer Ingelheim International GmbH
  • 16.7. Ceva Sante Animale
  • 16.8. Covetrus, Inc.
  • 16.9. Creative Biolabs, Inc.
  • 16.10. Dechra Pharmaceuticals PLC
  • 16.11. Elanco Animal Health Incorporated
  • 16.12. Genus plc
  • 16.13. Henry Schein Animal Health
  • 16.14. Heska Corporation
  • 16.15. Hester Biosciences Limited
  • 16.16. IDEXX Laboratories, Inc.
  • 16.17. IDvet SAS
  • 16.18. ImmuCell Corporation
  • 16.19. Indian Immunologicals Limited
  • 16.20. INDICAL Bioscience GmbH
  • 16.21. Intas Pharmaceuticals Limited
  • 16.22. Merck & Co., Inc.
  • 16.23. Neogen Corporation
  • 16.24. Neovet Diagnostics Pvt. Ltd.
  • 16.25. Pharmgate Animal Health LLC
  • 16.26. Phibro Animal Health Corporation
  • 16.27. Randox Laboratories Ltd.
  • 16.28. Recombinetics, Inc.
  • 16.29. Santa Cruz Biotechnology, Inc.
  • 16.30. Sequent Scientific Limited
  • 16.31. Thermo Fisher Scientific Inc.
  • 16.32. Trans Ova Genetics, L.C.
  • 16.33. Vetoquinol S.A.
  • 16.34. Virbac S.A.
  • 16.35. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIPASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIPASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIPASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHYTASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHYTASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHYTASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PROTEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PROTEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PROTEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GROWTH HORMONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GROWTH HORMONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GROWTH HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DNA VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DNA VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AVIAN CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AVIAN CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AVIAN CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INSECT CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INSECT CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INSECT CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAMMALIAN CELL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAMMALIAN CELL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAMMALIAN CELL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GENE EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TRANSGENIC TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TRANSGENIC TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TRANSGENIC TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PCR AND DNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PCR AND DNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PCR AND DNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PCR KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PCR KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PCR KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SANGER SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SANGER SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SANGER SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ELISA KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ELISA KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ELISA KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PCR-BASED TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PCR-BASED TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PCR-BASED TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PRECLINICAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PRECLINICAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PRECLINICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL TARGET IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL FEED ADDITIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL FEED ADDITIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CARBOHYDRASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CARBOHYDRASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CARBOHYDRASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PHYTASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PHYTASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PHYTASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PROTEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PROTEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PROTEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 269. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 272. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 273. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 274. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 276. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 277. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 278. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 280. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 281. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 284. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 285. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 320. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 321. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 323. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 324. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 325. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 326. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 327. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 328. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 329. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 331. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 332. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 333. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 334. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 335. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 336. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 337. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 338. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 340. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 341. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 342. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 343. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 344. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 345. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 346. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 348. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 349. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 350. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 351. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 352. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
  • TABLE 353. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 354. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 359. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 360. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 361. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
  • TABLE 362. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 363. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 364. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 366. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 367. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

TABLE 368